Page last updated: 2024-09-03

bq 610 and thromboxane a2

bq 610 has been researched along with thromboxane a2 in 1 studies

Compound Research Comparison

Studies
(bq 610)
Trials
(bq 610)
Recent Studies (post-2010)
(bq 610)
Studies
(thromboxane a2)
Trials
(thromboxane a2)
Recent Studies (post-2010) (thromboxane a2)
124135,617224429

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ajayi, AA; Hercule, HC; Mutembei, L; Ogungbade, GO; Oyekan, AO1

Other Studies

1 other study(ies) available for bq 610 and thromboxane a2

ArticleYear
Alteration in endothelin receptor sub-type responsiveness and in the endothelin-TXA(2) mimetic U46619 interaction, in type-2 hypertensive diabetic Zucker rats.
    Diabetes research and clinical practice, 2004, Volume: 63, Issue:3

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Animals; Antihypertensive Agents; Blood Flow Velocity; Blood Pressure; Diabetes Mellitus, Type 2; Drug Interactions; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Endothelin-1; Enzyme Inhibitors; Hypertension; Kidney Cortex; Kidney Medulla; Male; NG-Nitroarginine Methyl Ester; Oligopeptides; Piperidines; Platelet Aggregation; Rats; Rats, Sprague-Dawley; Rats, Zucker; Receptor Cross-Talk; Receptor, Endothelin A; Receptor, Endothelin B; Receptors, Endothelin; Thromboxane A2

2004